Werewolf Therapeutics Inc...
1.37
0.02 (1.48%)
At close: Jan 15, 2025, 3:59 PM
1.39
1.46%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -3.68 -1.15 -6.54 -30.89 -41.99
PS Ratio 6.90 3.61 n/a n/a n/a
PB Ratio 1.24 0.48 2.13 -8.9 -18.99
P/FCF Ratio -4.12 -1.34 -7.5 -24.06 -47.05
P/OCF Ratio -4.22 -1.46 -7.59 -24.78 -48.36
OCF/S Ratio -1.64 -2.48 n/a n/a n/a
Debt / Equity Ratio 0.47 0.12 0.10 -0.05 -0.13
Quick Ratio 7.14 5.84 13.56 17.58 8.84
Current Ratio 7.14 5.84 13.56 17.58 8.84
Asset Turnover 0.11 0.10 n/a n/a n/a
Interest Coverage -12.9 n/a n/a n/a -26.71
Return on Equity (ROE) -0.34 -0.42 -0.33 0.29 0.45
Return on Assets (ROA) -0.21 -0.32 -0.28 -0.15 -0.51
Return on Capital (ROIC) -0.26 -0.41 -0.3 -0.25 -0.51
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin -95.09% 84.70% n/a n/a n/a
Net Profit Margin -187.37% -314.4% n/a n/a n/a
Pretax Profit Margin -187.37% -328.09% n/a n/a n/a
Operating Profit Margin -203.09% -341.78% n/a n/a n/a
FCF Margin -167.38% -269.54% n/a n/a n/a
EBITDA Margin -162.79% -312.79% n/a n/a n/a